Hydromorphone Hydrochloride 43602-0004-30
- Manufacturer
- Ascent Pharmaceuticals Inc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- January 24, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA210506
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydromorphone Hydrochloride | 8 mg/1 |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Selected Package
43602-0004-30Selected30 TABLET in 1 BOTTLE (43602-004-30)
Other packages for this product(1)
500 TABLET in 1 BOTTLE (43602-004-05)